Mesoglycan for pain control after open excisional HAEMOrrhoidectomy (MeHAEMO): an observational multicentre study on behalf of the Italian Society of Colorectal Surgery (SICCR)
- PMID: 33092570
- PMCID: PMC7583301
- DOI: 10.1186/s12893-020-00914-5
Mesoglycan for pain control after open excisional HAEMOrrhoidectomy (MeHAEMO): an observational multicentre study on behalf of the Italian Society of Colorectal Surgery (SICCR)
Erratum in
-
Correction to: Mesoglycan for pain control after open excisional HAEMOrrhoidectomy (MeHAEMO): an observational multicentre study on behalf of the Italian Society of Colorectal Surgery (SICCR).BMC Surg. 2020 Nov 11;20(1):277. doi: 10.1186/s12893-020-00940-3. BMC Surg. 2020. PMID: 33176768 Free PMC article.
Abstract
Background: Excisional haemorrhoidectomy is the gold standard technique in patients with III and IV degree haemorrhoidal disease (HD). However, it is associated with a significant rate of post-operative pain. The aim of our study was to evaluate the efficacy of mesoglycan in the post-operative period of patients who underwent open excisional diathermy haemorrhoidectomy (OEH).
Methods: This was a retrospective multicentre observational study. Three hundred ninety-eight patients from sixteen colorectal referral centres who underwent OEH for III and IV HD were enrolled. All patients were followed-up on the first post-operative day (T1) and after 1 week (T2), 3 weeks (T3) and 6 weeks (T4). BMI, habits, SF-12 questionnaire, VAS at rest (VASs), after defecation (VASd), and after anorectal digital examination (VASe), bleeding and thrombosis, time to surgical wound healing and autonomy were evaluated.
Results: In the mesoglycan group, post-operative thrombosis was significantly reduced at T2 (p < 0.05) and T3 (p < 0.005), and all patients experienced less post-operative pain at each time point (p < 0.001 except for VASe T4 p = 0.003). There were no significant differences between the two groups regarding the time to surgical wound healing or post-operative bleeding. There was an early recovery of autonomy in the mesoglycan group in all three follow-up periods (T2 p = 0.016; T3 p = 0.002; T4 p = 0.007).
Conclusions: The use of mesoglycan led to a significant reduction in post-operative thrombosis and pain with consequent early resumption of autonomy. Trial registration NCT04481698-Mesoglycan for Pain Control After Open Excisional HAEMOrrhoidectomy (MeHAEMO) https://clinicaltrials.gov/ct2/show/NCT04481698?term=Mesoglycan+for+Pain+Control+After+Open+Excisional+HAEMOrrhoidectomy+%28MeHAEMO%29&draw=2&rank=1.
Keywords: Haemorrhoidal disease; Mesoglycan; Mucocutaneous bridges; Open excisional haemorrhoidectomy; Post-operative pain; Thrombosis.
Conflict of interest statement
The Authors declare that they have no competing interests. The Authors alone are responsible for the content and writing of the paper.
Figures
Similar articles
-
Correction to: Mesoglycan for pain control after open excisional HAEMOrrhoidectomy (MeHAEMO): an observational multicentre study on behalf of the Italian Society of Colorectal Surgery (SICCR).BMC Surg. 2020 Nov 11;20(1):277. doi: 10.1186/s12893-020-00940-3. BMC Surg. 2020. PMID: 33176768 Free PMC article.
-
Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter Study.Gastroenterol Res Pract. 2018 Mar 19;2018:6423895. doi: 10.1155/2018/6423895. eCollection 2018. Gastroenterol Res Pract. 2018. PMID: 29743886 Free PMC article.
-
Ligasure, Harmonic Scalpel versus conventional diathermy in excisional haemorrhoidectomy: a randomized controlled trial.ANZ J Surg. 2017 Apr;87(4):252-256. doi: 10.1111/ans.12838. Epub 2014 Sep 11. ANZ J Surg. 2017. PMID: 25214362 Clinical Trial.
-
Excisional Haemorrhoidectomy: Where Are We?Rev Recent Clin Trials. 2021;16(1):54-59. doi: 10.2174/1574887115666200319153439. Rev Recent Clin Trials. 2021. PMID: 32189597 Review.
-
Local Anaesthesia Alone Versus Regional or General Anaesthesia in Excisional Haemorrhoidectomy: A Systematic Review and Meta-Analysis.World J Surg. 2020 Sep;44(9):3119-3129. doi: 10.1007/s00268-020-05555-6. World J Surg. 2020. PMID: 32383052
Cited by
-
Postoperative pain after haemorrhoidal disease treatment: a still unsolved problem.Tech Coloproctol. 2023 Dec 10;28(1):6. doi: 10.1007/s10151-023-02889-w. Tech Coloproctol. 2023. PMID: 38071683 Free PMC article. No abstract available.
-
Strategies to Reduce Post-Hemorrhoidectomy Pain: A Systematic Review.Medicina (Kaunas). 2022 Mar 12;58(3):418. doi: 10.3390/medicina58030418. Medicina (Kaunas). 2022. PMID: 35334594 Free PMC article.
-
Effectiveness of preoperative micronized purified flavonoid fraction treatment and sucralfate-based rectal ointment on hemorrhoidal disease: A case-matched analysis.Tech Coloproctol. 2024 Sep 17;28(1):126. doi: 10.1007/s10151-024-02998-0. Tech Coloproctol. 2024. PMID: 39287845 Free PMC article.
-
The Role of Acupuncture in Relieving Post-Hemorrhoidectomy Pain: A Systematic Review of Randomized Controlled Trials.Front Surg. 2022 Mar 28;9:815618. doi: 10.3389/fsurg.2022.815618. eCollection 2022. Front Surg. 2022. PMID: 35419404 Free PMC article.
-
Clinical evidence and rationale of mesoglycan to treat chronic venous disease and hemorrhoidal disease: a narrative review.Updates Surg. 2024 Apr;76(2):423-434. doi: 10.1007/s13304-024-01776-9. Epub 2024 Feb 14. Updates Surg. 2024. PMID: 38356039 Free PMC article. Review.
References
-
- Gallo G, Sacco R, Sammarco G. Epidemiology of hemorrhoidal disease. In: Ratto C, Parello A, Litta F, editors. Hemorrhoids coloproctology. Cham: Springer; 2018. pp. 3–7.
-
- Ratto C, Campennì P, Papeo F, Donisi L, Litta F, Parello A. Transanal hemorrhoidal dearterialization (THD) for hemorrhoidal disease: a single-center study on 1000 consecutive cases and a review of the literature. Tech Coloproctol. 2017;21:953–962. doi: 10.1007/s10151-017-1726-5. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical